See more : Enea AB (publ) (ENEA.ST) Income Statement Analysis – Financial Results
Complete financial analysis of Advanced Oncotherapy plc (AVO.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Advanced Oncotherapy plc, a leading company in the Medical – Devices industry within the Healthcare sector.
- Mohit Industries Limited (MOHITIND.BO) Income Statement Analysis – Financial Results
- ESI Group SA (ESI.PA) Income Statement Analysis – Financial Results
- Abcam plc (ABC.L) Income Statement Analysis – Financial Results
- BBD Initiative Inc. (5259.T) Income Statement Analysis – Financial Results
- Veolia Environnement S.A. (VEOEF) Income Statement Analysis – Financial Results
Advanced Oncotherapy plc (AVO.L)
About Advanced Oncotherapy plc
Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.
Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.05K | 26.81K | 106.38K | 68.92K | 100.00K | 6.16M | 1.38M | 3.42M | 2.86M | 2.12M | 1.34M | 1.75M | 562.00K |
Cost of Revenue | 0.00 | 2.34M | 2.33M | 2.03M | 1.91M | 365.47K | 345.37K | 33.75K | 202.68K | 155.95K | 713.00 | 5.21M | 1.18M | 455.00K | 416.00K | 163.00K | 35.00K | 73.00K | 20.00K |
Gross Profit | 0.00 | -2.34M | -2.33M | -2.03M | -1.91M | -365.47K | -336.33K | -6.95K | -96.30K | -87.04K | 99.29K | 953.00K | 200.00K | 2.96M | 2.44M | 1.95M | 1.30M | 1.68M | 542.00K |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -3,718.36% | -25.92% | -90.53% | -126.29% | 99.29% | 15.47% | 14.49% | 86.68% | 85.43% | 92.29% | 97.38% | 95.82% | 96.44% |
Research & Development | 0.00 | 140.00 | 100.00K | 100.00K | 100.00K | 2.52M | 2.47K | 3.79K | 1.66K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 23.74M | 20.27M | 20.66M | 19.89M | 14.49M | 13.09M | 7.62M | 5.55M | 2.04M | 1.16M | 1.63M | 1.39M | 1.81M | 1.73M | 1.85M | 1.89M | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 23.74M | 20.27M | 20.66M | 19.89M | 14.49M | 13.09M | 7.62M | 5.55M | 2.04M | 1.16M | 1.63M | 1.39M | 1.81M | 1.73M | 1.85M | 1.89M | 0.00 | 0.00 |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -12.74M | -7.58M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 0.00 | 23.74M | 20.27M | 20.66M | 19.89M | 14.49M | 13.09M | 7.62M | 5.55M | 2.04M | 1.16M | 1.63M | 1.39M | 1.81M | 1.73M | -803.00K | 2.46M | 714.00K | 405.00K |
Cost & Expenses | 0.00 | 23.74M | 20.27M | 20.66M | 21.80M | 14.49M | 13.09M | 7.62M | 5.76M | 2.19M | 1.16M | 6.83M | 2.57M | 2.26M | 2.15M | -640.00K | 2.49M | 787.00K | 425.00K |
Interest Income | 0.00 | 5.06K | 3.30K | 15.57K | 13.50K | 2.00K | 9.05K | 26.81K | 499.28K | 8.00 | 3.72K | 0.00 | 1.00K | 4.00K | 1.21M | 258.00K | 187.00K | 244.00K | 93.00K |
Interest Expense | 0.00 | 5.76M | 5.03M | 1.23M | 80.19K | 1.99M | 106.34K | 151.15K | 377.18K | 257.81K | 322.94K | 696.00K | 742.00K | 2.96M | 2.55M | 1.35M | 1.09M | 1.16M | 388.00K |
Depreciation & Amortization | 228.49K | 2.34M | 2.34M | 2.04M | 424.63K | 365.47K | 345.37K | 33.75K | 117.62K | 82.48K | 508.50K | 99.00K | 27.00K | 33.00K | 38.00K | 34.00K | 33.00K | 34.00K | 9.00K |
EBITDA | 0.00 | -21.40M | -17.93M | -18.62M | -21.44M | -14.13M | -12.73M | -7.56M | -5.03M | -2.04M | -1.06M | -573.00K | -1.21M | 1.79M | 297.00K | 3.05M | 2.59M | 958.00K | 239.00K |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -140,772.70% | -28,193.93% | -4,731.37% | -2,962.30% | -1,056.01% | -9.30% | -87.90% | 52.27% | 10.40% | 144.07% | 194.16% | 54.81% | 42.53% |
Operating Income | 0.00 | -23.74M | -20.27M | -20.66M | -21.80M | -14.49M | -13.09M | -8.51M | -6.45M | -3.17M | -1.56M | -972.00K | -2.79M | -506.00K | -967.00K | 2.74M | 2.33M | 603.00K | 111.00K |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -144,691.07% | -31,729.30% | -6,066.04% | -4,604.65% | -1,564.52% | -15.78% | -202.46% | -14.82% | -33.86% | 129.55% | 174.70% | 34.50% | 19.75% |
Total Other Income/Expenses | 0.00 | -5.76M | -5.03M | -1.22M | -18.90K | -1.99M | -97.29K | -1.01M | -1.29M | -257.80K | -319.22K | -696.00K | -742.00K | -2.96M | -1.25M | -1.09M | -873.00K | -898.00K | -295.00K |
Income Before Tax | 0.00 | -29.49M | -25.30M | -21.88M | -21.87M | -16.49M | -13.18M | -8.63M | -6.33M | -3.43M | -1.88M | -1.67M | -3.54M | -3.47M | -2.21M | 1.65M | 1.46M | -295.00K | -184.00K |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -145,766.72% | -32,193.20% | -5,951.26% | -4,978.74% | -1,883.73% | -27.07% | -256.23% | -101.46% | -77.52% | 78.20% | 109.36% | -16.88% | -32.74% |
Income Tax Expense | 0.00 | 5.76M | 5.03M | -1.08M | -759.41K | -2.83M | -2.82M | -2.78M | 2.43M | 1.55M | 829.88K | -288.00K | -119.00K | -1.70M | -524.00K | 144.00K | 1.03M | 88.00K | 119.00K |
Net Income | 0.00 | -35.25M | -30.33M | -20.79M | -21.11M | -13.66M | -10.35M | -6.56M | -7.46M | -3.94M | -2.71M | -6.49M | -4.09M | -1.90M | -1.69M | 1.35M | 678.00K | -383.00K | -184.00K |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -114,390.93% | -24,456.22% | -7,015.85% | -5,711.72% | -2,713.61% | -105.39% | -296.67% | -55.72% | -59.10% | 63.97% | 50.75% | -21.91% | -32.74% |
EPS | 0.00 | -0.09 | -0.10 | -0.10 | -0.14 | -0.18 | -0.17 | -0.13 | -0.22 | -0.25 | -0.39 | -2.11 | -1.33 | -0.62 | -0.55 | 0.45 | 0.23 | -0.12 | -0.06 |
EPS Diluted | 0.00 | -0.09 | -0.10 | -0.10 | -0.14 | -0.18 | -0.17 | -0.13 | -0.22 | -0.25 | -0.39 | -2.11 | -1.33 | -0.62 | -0.55 | 0.45 | 0.23 | -0.12 | -0.06 |
Weighted Avg Shares Out | 0.00 | 382.48M | 288.98M | 211.48M | 150.54M | 77.83M | 60.80M | 51.16M | 33.94M | 16.06M | 7.05M | 3.07M | 3.07M | 3.07M | 3.07M | 3.07M | 2.93M | 3.07M | 3.07M |
Weighted Avg Shares Out (Dil) | 0.00 | 382.48M | 288.98M | 211.48M | 150.54M | 77.83M | 60.80M | 51.16M | 33.94M | 16.06M | 7.05M | 3.07M | 3.07M | 3.07M | 3.07M | 3.16M | 2.94M | 3.07M | 3.07M |
Source: https://incomestatements.info
Category: Stock Reports